CVD
-
Getting to the heart of CVD
Cardiovascular diseases are the world’s leading cause of death. Experts and journalists from around the world converge on Beijing for the World Congress of Cardiology Bayer scientific roundtable to discuss the problem. LEE KOK LEONG travels to China to report.
CVD | 01 August 2010
-
Big Pharma Struggles to Benefit from Increased CVD Drug Usage
Pharmaceutical (Pharma) companies will struggle to profit from the Cardiovascular Disease (CVD) market over the next decade despite growing drug usage, according to Datamonitor. It is predicted that the CVD pharma market will grow from US$99 billion …
CVD | 17 March 2010
-
Telmisartan as effective as Ramipril but with better long-term tolerability
New results from the landmark ONTARGET Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (Micardis) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of car…
CVD | 27 October 2008
-
Statins in Managing CVD
Advancements in statin therapy on atherosclerosis management.
CVD | 01 September 2008
